Novel Methylated DNA Markers Discriminate Advanced Neoplasia in Pancreatic Cysts: Marker Discovery, Tissue Validation, and Cyst Fluid Testing

OBJECTIVES: Pancreatic cystic lesions (PCLs) may be precancerous. Those likely to harbor high-grade dysplasia (HGD) or pancreatic cancer (PC) are targets for surgical resection. Current algorithms to predict advanced neoplasia (HGD/PC) in PCLs lack diagnostic accuracy. In pancreatic tissue and cystf...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Gastroenterol
Main Authors: Majumder, Shounak, Taylor, William R., Yab, Tracy C., Berger, Calise K., Dukek, Brian A., Cao, Xiaoming, Foote, Patrick H., Wu, Chung Wah, Mahoney, Douglas W., Aslanian, Harry R., Castillo, Carlos Fernández-Del, Doyle, Leona A., Farrell, James J., Fisher, William E., Lee, Linda S., Lee, Yvonne N., Park, Walter, Rodrigues, Clifton, Rothberg, Bonnie Elyssa Gould, Salem, Ronald R., Simeone, Diane M., Urs, Sumithra, Van Buren, George, Smyrk, Thomas C., Allawi, Hatim T., Lidgard, Graham P., Raimondo, Massimo, Chari, Suresh T., Kendrick, Michael L., Kisiel, John B., Topazian, Mark D., Ahlquist, David A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7294458/
https://ncbi.nlm.nih.gov/pubmed/31306149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14309/ajg.0000000000000284
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados